← MyLongPath

NAD+ infusion

TherapyExperimental0 reviews
Average score out of 5
ExperimentalThis treatment is under research. Available data is limited. Consult your doctor before making any decision.

NAD+ is a coenzyme central to cellular metabolism and redox balance. Intravenous infusions aim to restore cellular NAD+ levels, potentially improving energy production and reducing fatigue in Long COVID.

Information
Subcategory
Intravenous therapy
Evidence level
2/5
Evidence type
Preclinical studies and case reports
Share your experience

Your feedback helps thousands of people find what really works.

Join the community